Alaunos Therapeutics (TCRT) Capital Expenditures Growth (5y) (2015 - 2025)
Alaunos Therapeutics (TCRT) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-80.73% |
| Sep 30, 2023 |
-64.16% |
| Jun 30, 2023 |
-9.79% |
| Mar 31, 2023 |
-16.47% |
| Dec 31, 2022 |
-15.92% |
| Sep 30, 2022 |
-28.70% |
| Jun 30, 2022 |
16.12% |
| Mar 31, 2022 |
-39.51% |
| Dec 31, 2021 |
34.36% |
| Sep 30, 2021 |
11.78% |
| Jun 30, 2021 |
80.43% |
| Mar 31, 2021 |
34.15% |
| Dec 31, 2020 |
57.63% |
| Sep 30, 2020 |
340.68% |
| Jun 30, 2020 |
152.48% |
| Mar 31, 2020 |
97.67% |
| Sep 30, 2019 |
2.62% |
| Jun 30, 2019 |
-7.13% |
| Mar 31, 2019 |
37.97% |
| Dec 31, 2018 |
-53.83% |
